Ralf Rosskamp
2020
Compensation breakdown
Non-Equity Incentive Plan | $692,110 |
---|---|
Option Awards | $2,642,015 |
Salary | $356,250 |
Stock Awards | $625,490 |
Other | $18,964 |
Total | $4,334,829 |
Rosskamp received $2.6M in option awards, accounting for 61% of the total pay in 2020.
Rosskamp also received $692.1K in non-equity incentive plan, $356.3K in salary, $625.5K in stock awards and $19K in other compensation.
Rankings
In 2020, Ralf Rosskamp's compensation ranked 2,612th out of 13,090 executives tracked by ExecPay. In other words, Rosskamp earned more than 80.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,612 | 80th |
Manufacturing | 1,005 | 82nd |
Chemicals And Allied Products | 372 | 84th |
Drugs | 320 | 84th |
Pharmaceutical Preparations | 235 | 84th |
Pay ratio
Ralf Rosskamp's Pay | $4,334,829 |
---|---|
Median Employee's Pay | $311,375 |
Pay Ratio | 14to 1 |
In 2020, the annual total compensation of Ralf Rosskamp was $4,334,829.
The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.
The ratio of Ralf Rosskamp's pay to the pay of median employee was therefore 14 to one.
Rosskamp's colleagues
We found six more compensation records of executives who worked with Ralf Rosskamp at Dicerna Pharmaceuticals in 2020.
2020
Douglas Fambrough
Dicerna Pharmaceuticals
Chief Executive Officer
2020
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
2020
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
2020
James Weissman
Dicerna Pharmaceuticals
Chief Operating Officer
2020
Shreeram Aradhye
Dicerna Pharmaceuticals
Chief Medical Officer
2020
Douglas Pagán
Dicerna Pharmaceuticals